Toll-like receptor signaling and sigirr in renal fibrosis upon unilateral ureteral obstruction

PLoS ONE

Volumn 6, Issue 4, 2011, Pages

  Skuginna, Veronika ^a   Lech, Maciej ^a   Allam, Ramanjaneyulu ^a   Ryu, Mi ^a   Clauss, Sebastian ^a   Susanti, Heni Eka ^a   Römmele, Christoph ^a   Garlanda, Cecilia ^b   Mantovani, Alberto ^b   Anders, Hans Joachim ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN TYPE 1; COLLAGEN TYPE 1 ALPHA; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 6; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN INHIBITOR; PROTEIN SIGIRR; SMOOTH MUSCLE ACTIN; THY 1 ANTIGEN; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG; MYD88 PROTEIN, MOUSE; TIR8 PROTEIN, MOUSE; TLR2 PROTEIN, MOUSE; TLR9 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FIBROBLAST; FIBROSING ALVEOLITIS; GENE EXPRESSION; IMMUNOCOMPETENT CELL; IN VITRO STUDY; KIDNEY CELL; KIDNEY DISEASE; KIDNEY FIBROSIS; KIDNEY TUBULE ATROPHY; MACROPHAGE; MORPHOMETRICS; MOUSE; MYOFIBROBLAST; NONHUMAN; NUCLEOTIDE SEQUENCE; SIGNAL TRANSDUCTION; T LYMPHOCYTE; UNILATERAL URETERAL OBSTRUCTION; URETER OBSTRUCTION; ANIMAL; FIBROSIS; GENETICS; KIDNEY; METABOLISM; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

MUS;

ANIMALS; FIBROSIS; KIDNEY; KIDNEY DISEASES; MICE; MICE, MUTANT STRAINS; MYELOID DIFFERENTIATION FACTOR 88; RECEPTORS, INTERLEUKIN-1; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 2; TOLL-LIKE RECEPTOR 9; TOLL-LIKE RECEPTORS; URETERAL OBSTRUCTION;

EID: 79955531653     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0019204     Document Type: Article

References (44)

1. Zeisberg M, Neilson EG, (2010) Mechanisms of tubulointerstitial fibrosis. J Am Soc Nephrol 21: 1819-1834.
2. Nangaku M, (2006) Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 17: 17-25.
3. Liu Y, (2010) New insights into epithelial-mesenchymal transition in kidney fibrosis. J Am Soc Nephrol 21: 212-222.
4. Wada T, Sakai N, Matsushima K, Kaneko S, (2007) Fibrocytes: a new insight into kidney fibrosis. Kidney Int 72: 269-273.
5. Rosenbloom J, Castro SV, Jimenez SA, (2010) Narrative review: fibrotic diseases: cellular and molecular mechanisms and novel therapies. Ann Intern Med 152: 159-166.
6. Ninichuk V, Anders HJ, (2008) Bone marrow-derived progenitor cells and renal fibrosis. Front Biosci 13: 5163-5173.
7. Medzhitov R, (2008) Origin and physiological roles of inflammation. Nature 454: 428-435.
8. Akira S, (2009) Innate immunity to pathogens: diversity in receptors for microbial recognition. Immunol Rev 227: 5-8.
9. Anders HJ, (2010) Toll-like receptors and danger signaling in kidney injury. J Am Soc Nephrol 21: 1270-1274.
10. Kono H, Rock KL, (2008) How dying cells alert the immune system to danger. Nat Rev Immunol 8: 279-289.
11. Anders HJ, Schlondorff D, (2007) Toll-like receptors: emerging concepts in kidney disease. Curr Opin Nephrol Hypertens 16: 177-183.
12. Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJ, et al. (2005) Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 115: 2894-2903.
13. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, et al. (2007) TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117: 2847-2859.
14. Shigeoka AA, Holscher TD, King AJ, Hall FW, Kiosses WB, et al. (2007) TLR2 is constitutively expressed within the kidney and participates in ischemic renal injury through both MyD88-dependent and-independent pathways. J Immunol 178: 6252-6258.
15. Rusai K, Sollinger D, Baumann M, Wagner B, Strobl M, et al. (2010) Toll-like receptors 2 and 4 in renal ischemia/reperfusion injury. Pediatr Nephrol.
16. Cunningham PN, Wang Y, Guo R, He G, Quigg RJ, (2004) Role of Toll-like receptor 4 in endotoxin-induced acute renal failure. J Immunol 172: 2629-2635.
17. Zhang B, Ramesh G, Uematsu S, Akira S, Reeves WB, (2008) TLR4 signaling mediates inflammation and tissue injury in nephrotoxicity. J Am Soc Nephrol 19: 923-932.
18. Yasuda H, Leelahavanichkul A, Tsunoda S, Dear JW, Takahashi Y, et al. (2008) Chloroquine and inhibition of Toll-like receptor 9 protect from sepsis-induced acute kidney injury. Am J Physiol Renal Physiol 294: F1050-1058.
19. Wang S, Schmaderer C, Kiss E, Schmidt C, Bonrouhi M, et al. (2010) Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling. Dis Model Mech 3: 92-103.
20. Bascands JL, Schanstra JP, (2005) Obstructive nephropathy: insights from genetically engineered animals. Kidney Int 68: 925-937.
21. Chevalier RL, Forbes MS, Thornhill BA, (2009) Ureteral obstruction as a model of renal interstitial fibrosis and obstructive nephropathy. Kidney Int 75: 1145-1152.
22. Leemans JC, Butter LM, Pulskens WP, Teske GJ, Claessen N, et al. (2009) The role of Toll-like receptor 2 in inflammation and fibrosis during progressive renal injury. PLoS One 4: e5704.
23. Campbell MT, Hile KL, Zhang H, Asanuma H, Vanderbrink BA, et al. (2009) Toll-Like Receptor 4: A Novel Signaling Pathway During Renal Fibrogenesis. J Surg Res.
24. O'Neill LA, (2008) When signaling pathways collide: positive and negative regulation of toll-like receptor signal transduction. Immunity 29: 12-20.
25. Garlanda C, Anders HJ, Mantovani A, (2009) TIR8/SIGIRR: an IL-1R/TLR family member with regulatory functions in inflammation and T cell polarization. Trends Immunol 30: 439-446.
26. Lech M, Garlanda C, Mantovani A, Kirschning CJ, Schlondorff D, et al. (2007) Different roles of TiR8/Sigirr on toll-like receptor signaling in intrarenal antigen-presenting cells and tubular epithelial cells. Kidney Int 72: 182-192.
27. Lech M, Kulkarni OP, Pfeiffer S, Savarese E, Krug A, et al. (2008) Tir8/Sigirr prevents murine lupus by suppressing the immunostimulatory effects of lupus autoantigens. J Exp Med 205: 1879-1888.
28. Lech M, Skuginna V, Kulkarni OP, Gong J, Wei T, et al. (2009) Lack of SIGIRR/TIR8 aggravates hydrocarbon oil-induced lupus nephritis. J Pathol.
29. Noris M, Cassis P, Azzollini N, Cavinato R, Cugini D, et al. (2009) The Toll-IL-1R member Tir8/SIGIRR negatively regulates adaptive immunity against kidney grafts. J Immunol 183: 4249-4260.
30. Lech M, Avila-Ferrufino A, Allam R, Segerer S, Khandoga A, et al. (2009) Resident dendritic cells prevent postischemic acute renal failure by help of single Ig IL-1 receptor-related protein. J Immunol 183: 4109-4118.
31. Anders HJ, (2007) Innate pathogen recognition in the kidney: toll-like receptors, NOD-like receptors, and RIG-like helicases. Kidney Int 72: 1051-1056.
32. Gong J, Wei T, Stark RW, Jamitzky F, Heckl WM, et al. (2009) Inhibition of Toll-like receptors TLR4 and 7 signaling pathways by SIGIRR: A computational approach. J Struct Biol.
33. Patole PS, Schubert S, Hildinger K, Khandoga S, Khandoga A, et al. (2005) Toll-like receptor-4: renal cells and bone marrow cells signal for neutrophil recruitment during pyelonephritis. Kidney Int 68: 2582-2587.
34. Pulskens WP, Rampanelli E, Teske GJ, Butter LM, Claessen N, et al. (2010) TLR4 promotes fibrosis but attenuates tubular damage in progressive renal injury. J Am Soc Nephrol 21: 1299-1308.
35. Chowdhury P, Sacks SH, Sheerin NS, (2010) Endogenous ligands for TLR2 and TLR4 are not involved in renal injury following ureteric obstruction. Nephron Exp Nephrol 115: e122-130.
36. Lichtnekert J, Vielhauer V, Zecher D, Kulkarni OP, Clauss S, et al. (2009) Trif is not required for immune complex glomerulonephritis: dying cells activate mesangial cells via Tlr2/Myd88 rather than Tlr3/Trif. Am J Physiol Renal Physiol 296: F867-874.
37. Garlanda C, Riva F, Polentarutti N, Buracchi C, Sironi M, et al. (2004) Intestinal inflammation in mice deficient in Tir8, an inhibitory member of the IL-1 receptor family. Proc Natl Acad Sci U S A 101: 3522-3526.
38. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S, (1999) Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11: 115-122.
39. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, et al. (1999) Differential roles of TLR2 and TLR4 in recognition of gram-negative and gram-positive bacterial cell wall components. Immunity 11: 443-451.
40. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, et al. (2000) A Toll-like receptor recognizes bacterial DNA. Nature 408: 740-745.
41. Higgins DF, Lappin DW, Kieran NE, Anders HJ, Watson RW, et al. (2003) DNA oligonucleotide microarray technology identifies fisp-12 among other potential fibrogenic genes following murine unilateral ureteral obstruction (UUO): modulation during epithelial-mesenchymal transition. Kidney Int 64: 2079-2091.
42. Ninichuk V, Khandoga AG, Segerer S, Loetscher P, Schlapbach A, et al. (2007) The role of interstitial macrophages in nephropathy of type 2 diabetic db/db mice. Am J Pathol 170: 1267-1276.
43. Ninichuk V, Gross O, Reichel C, Khandoga A, Pawar RD, et al. (2005) Delayed chemokine receptor 1 blockade prolongs survival in collagen 4A3-deficient mice with Alport disease. J Am Soc Nephrol 16: 977-985.
44. Clayton A, Steadman R, Williams JD, (1997) Cells isolated from the human cortical interstitium resemble myofibroblasts and bind neutrophils in an ICAM-1-dependent manner. J Am Soc Nephrol 8: 604-615.